We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections

By LabMedica International staff writers
Posted on 29 Sep 2025

Candida bloodstream infections are a growing global health threat, causing an estimated 6 million cases and 3. More...

8 million deaths annually. Hospitals are particularly vulnerable, as weakened patients after surgery or chemotherapy face high risks, while the fungus can also cling to catheters and prostheses, forming drug-resistant biofilms. Current diagnostic methods rely on slow lab cultures that often take days, leading to delays in treatment and poor outcomes. Researchers have now developed a method that uses sugar fingerprints to rapidly detect these infections at the bedside.

Scientists at the Max Planck Institute of Colloids and Interfaces (Brandenburg, Germany), along with collaborators, created synthetic replicas of Candida sugars to study immune responses. By analyzing the sugar-rich outer wall of the fungus, which makes up about 80% of its surface, the team identified unique glycan “fingerprints.” These glycans were printed on microarrays and exposed to serum samples, revealing how antibodies bind to specific fungal sugars recognized by the immune system.

In laboratory testing, the approach allowed researchers to distinguish between infected and healthy samples with high precision. Fluorescent tagging of glycans made antibody binding instantly visible, acting as a measurable signal. The study, published in PNAS, showed that this method reliably identified which glycan structures triggered the strongest immune reactions, paving the way for a fast and consistent diagnostic tool.

The findings suggest that a simple bedside test strip using minimal blood could return results in minutes, replacing invasive procedures and reducing infection risks from multiple blood draws. The technique could also distinguish between different Candida species, giving clinicians timely information to isolate patients and prescribe targeted treatments. This rapid diagnostic approach is especially valuable in regions without access to advanced culture labs.

In addition to diagnostics, the research opens the door to preventive measures. Precisely defined glycans identified through this work may serve as building blocks for future vaccines targeting Candida’s sugar-coated surface. Glycoconjugate vaccines, already successful against bacterial pathogens, could be adapted to fungal infections, providing long-term immune protection for high-risk patients.

“Fast diagnosis can save lives; doctors cannot afford to let Candida spread while waiting for results,” said researcher Dr. Rosanne Sprute.

Related Links:
Max Planck Institute of Colloids and Interfaces


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
New
Homocysteine Quality Control
Liquichek Homocysteine Control
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.